L Mizen
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
Papers in ⓘ
-
- Antibiotic Resistance in Bacteria 8
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 14
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- R. Sutherland (1 shared paper)Gary Woodnutt (9 shared papers)C. Edward Dixon (1 shared paper)P. Acred (3 shared papers)Valerie Berry (4 shared papers)Martin Cole (2 shared papers)Stephen W. Elson (2 shared papers)James Clayton (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Journal of Antimicrobial Chemotherapy (3 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Antibiotics (1 paper)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
L Mizen
22 papers receiving 304 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 79
- Pharmacology 149
- Clinical Biochemistry 36
- Applied Microbiology and Biotechnology 8
- Microbiology 20
Countries citing papers authored by L Mizen
This map shows the geographic impact of L Mizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Mizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Mizen more than expected).
Fields of papers citing papers by L Mizen
This network shows the impact of papers produced by L Mizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Mizen. The network helps show where L Mizen may publish in the future.
Co-authors
The 20 scholars most cited alongside L Mizen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1977 | 90 | |
| 2 | 1977 | 28 | |
| 3 | -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation. | 1970 | 27 |
| 4 | 1976 | 27 | |
| 5 | 1970 | 22 | |
| 6 | 1975 | 21 | |
| 7 | 1991 | 19 | |
| 8 | 1989 | 16 | |
| 9 | 1992 | 15 | |
| 10 | 1995 | 13 | |
| 11 | 1988 | 12 | |
| 12 | 1998 | 12 | |
| 13 | 2006 | 11 | |
| 14 | 1988 | 11 | |
| 15 | 1992 | 9 | |
| 16 | 1987 | 6 | |
| 17 | 1995 | 5 | |
| 18 | 1966 | 3 | |
| 19 | 1990 | 2 | |
| 20 | 2012 | 2 |
About L Mizen
L Mizen is a scholar working on Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, Microbiology and Clinical Biochemistry, having authored 23 papers that have together received 355 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (8 papers), Infective Endocarditis Diagnosis and Management (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Analytical Chemistry and Chromatography (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Molecular Medicine (79 citations), Pharmacology (149 citations), Clinical Biochemistry (36 citations), Applied Microbiology and Biotechnology (8 citations) and Microbiology (20 citations). L Mizen has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include R. Sutherland, Gary Woodnutt, C. Edward Dixon, P. Acred, Valerie Berry, Martin Cole, Stephen W. Elson, James Clayton, George Burton and D. M. Brown. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Medicinal Chemistry, The Journal of Antibiotics and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.